RNA-seq analysis of murine microglial BV2 cells treated with interferon-gamma (IFNγ)

BV2 cells were treated with IFNγ. Wildtype cells were compared to cells made deficient for Atg5 via CRISPR/Cas9. Independent biological replicates for each condition were pooled in a single library.以干扰素γ (IFNγ) 处理BV2细胞。将野生型细胞与通过CRISPR/Cas9技术构建的自噬相关基因5 (Atg5) 缺陷细胞进行比较。将各实验条件下的独立生物学重复混合至单个文库中。